Macrogenics Stock Investor Sentiment

MGNX Stock  USD 3.41  0.07  2.10%   
Slightly above 58% of all MacroGenics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding MacroGenics suggests that some traders are interested. MacroGenics' investing sentiment can be driven by a variety of factors including economic data, MacroGenics' earnings reports, geopolitical events, and overall market trends.
  

MacroGenics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
17 hours ago at gurufocus.com         
MGNX ALERT Bragar Eagel Squire, P.C. is Investigating Macrogenics, Inc. ...
Gurufocus Stories at Macroaxis
a day ago at news.google.com         
MacroGenics, Inc. Investors Reminder Kessler Topaz Meltzer Check, LLP Reminds MacroGenics, Inc. Shar...
Google News at Macroaxis
six days ago at businesswire.com         
Breast Cancer Therapeutics Global Market Overview 2021-2030 HER2-Targeted and Immunotherapies Lead A...
businesswire News
over a week ago at finance.yahoo.com         
Breast Cancer Therapeutics Global Market Research 2024 Advancements in Targeted and Immunotherapies ...
Yahoo News
over two weeks ago at investing.com         
MacroGenics appoints new financial officer
Investing News at Macroaxis
over two weeks ago at news.google.com         
MacroGenics Announces Leadership Transition in Financial Roles - TipRanks
Google News at Macroaxis
over two weeks ago at news.google.com         
MacroGenics Announces CEO Transition Amidst Strong Growth - MSN
Google News at Macroaxis
over three weeks ago at gurufocus.com         
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Macrogenics Inc
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
WLGS Stock Drops 7.6 percent Amidst Volatile Construction Sector
Gurufocus Stories at Macroaxis
over three weeks ago at investing.com         
MacroGenics SWOT analysis biotech stock faces pipeline hurdles amid cash strength
Investing News at Macroaxis
over a month ago at thelincolnianonline.com         
MacroGenics Cut to Market Perform at JMP Securities
news
over a month ago at finance.yahoo.com         
MacroGenics Third Quarter 2024 Earnings Beats Expectations
Yahoo News
over a month ago at insidermonkey.com         
MacroGenics, Inc. Q2 2024 Earnings Call Transcript
insidermonkey News
over a month ago at simplywall.st         
MacroGenics Third Quarter 2024 Earnings Beats Expectations
Simply Wall St News at Macroaxis
over a month ago at seekingalpha.com         
MacroGenics downgraded to market perform by JMP, price target removed
seekingalpha News
Far too much social signal, news, headlines, and media speculation about MacroGenics that are available to investors today. That information is available publicly through MacroGenics media outlets and privately through word of mouth or via MacroGenics internal channels. However, regardless of the origin, that massive amount of MacroGenics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MacroGenics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MacroGenics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MacroGenics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MacroGenics alpha.

MacroGenics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
MacroGenics, Inc. Class Action Levi Korsinsky Reminds MacroGenics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 24, ...
09/17/2024
2
MGNX LAWSUIT ALERT Levi Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
09/20/2024
3
MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm
09/24/2024
4
Acquisition by Koenig Scott of 374215 shares of MacroGenics subject to Rule 16b-3
09/25/2024
5
Disposition of 53265 shares by Koenig Scott of MacroGenics subject to Rule 16b-3
10/07/2024
6
Earnings To Watch Macrogenics Inc Reports Q3 2024 Result
11/04/2024
7
MacroGenics GAAP EPS of 0.90 beats by 0.81, revenue of 110.7M beats by 23.12M
11/05/2024
8
Heres What Key Metrics Tell Us About MacroGenics Q3 Earnings
11/06/2024
9
MacroGenics, Inc. Q2 2024 Earnings Call Transcript
11/07/2024
10
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Macrogenics Inc
11/15/2024
11
MacroGenics appoints new financial officer
11/22/2024
12
MacroGenics, Inc. Investors Reminder Kessler Topaz Meltzer Check, LLP Reminds MacroGenics, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsui...
12/10/2024

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.